$1.5 Billion is the total value of CLOUGH CAPITAL PARTNERS L P's 111 reported holdings in Q4 2021. The portfolio turnover from Q3 2021 to Q4 2021 was 100.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
IRL | Exit | NEW IRELAND FD INC | $0 | – | -11,319 | -100.0% | -0.01% | – |
ZLAB | Exit | ZAI LAB LTDadr | $0 | – | -2,250 | -100.0% | -0.01% | – |
GGT | Exit | GABELLI MULTIMEDIA TR INC | $0 | – | -30,483 | -100.0% | -0.02% | – |
MGU | Exit | MACQUARIE GLOBAL INFRASTRUCT | $0 | – | -12,464 | -100.0% | -0.02% | – |
JSD | Exit | NUVEEN SHORT DURATION CR OPP | $0 | – | -24,540 | -100.0% | -0.02% | – |
BIDU | Exit | BAIDU INCspon adr rep a | $0 | – | -2,700 | -100.0% | -0.02% | – |
GAM | Exit | GENERAL AMERN INVS CO INC | $0 | – | -10,000 | -100.0% | -0.03% | – |
AEF | Exit | ABERDEEN EMRG MRKTS EQT INM | $0 | – | -53,444 | -100.0% | -0.03% | – |
ETY | Exit | EATON VANCE TAX-MANAGED DIVE | $0 | – | -40,085 | -100.0% | -0.03% | – |
AIF | Exit | APOLLO TACTICAL INCOME FD IN | $0 | – | -47,325 | -100.0% | -0.04% | – |
KMF | Exit | KAYNE ANDERSON NEXTGEN ENRGY | $0 | – | -109,756 | -100.0% | -0.05% | – |
AFT | Exit | APOLLO SR FLOATING RATE FD I | $0 | – | -52,061 | -100.0% | -0.05% | – |
GGM | Exit | GUGGENHEIM CR ALLOCATION FD | $0 | – | -40,200 | -100.0% | -0.05% | – |
CRF | Exit | CORNERSTONE TOTAL RETURN FD | $0 | – | -86,900 | -100.0% | -0.06% | – |
TEI | Exit | TEMPLETON EMERGING MKTS INCO | $0 | – | -142,788 | -100.0% | -0.07% | – |
CLM | Exit | CORNERSTONE STRATEGIC VALUE | $0 | – | -107,850 | -100.0% | -0.08% | – |
PCI | Exit | PIMCO DYNAMIC CR INCOME FD | $0 | – | -72,000 | -100.0% | -0.09% | – |
GAB | Exit | GABELLI EQUITY TR INC | $0 | – | -293,362 | -100.0% | -0.12% | – |
W | Exit | WAYFAIR INCcl a | $0 | – | -11,300 | -100.0% | -0.18% | – |
GIM | Exit | TEMPLETON GLOBAL INCOME FD | $0 | – | -583,189 | -100.0% | -0.19% | – |
BST | Exit | BLACKROCK SCIENCE & TECHNOLO | $0 | – | -67,853 | -100.0% | -0.22% | – |
XOP | Exit | SPDR SER TRs&p oilgas exp | $0 | – | -52,100 | -100.0% | -0.31% | – |
GPM | Exit | GUGGENHEIM ENHANCED EQT INCM | $0 | – | -551,702 | -100.0% | -0.31% | – |
RPTX | Exit | REPARE THERAPEUTICS INC | $0 | – | -221,879 | -100.0% | -0.35% | – |
MA | Exit | MASTERCARD INCORPORATEDcl a | $0 | – | -20,278 | -100.0% | -0.43% | – |
ONEM | Exit | 1LIFE HEALTHCARE INC | $0 | – | -384,800 | -100.0% | -0.47% | – |
ZBH | Exit | ZIMMER BIOMET HOLDINGS INC | $0 | – | -54,770 | -100.0% | -0.49% | – |
EEFT | Exit | EURONET WORLDWIDE INC | $0 | – | -70,720 | -100.0% | -0.55% | – |
ZI | Exit | ZOOMINFO TECHNOLOGIES INC | $0 | – | -160,000 | -100.0% | -0.59% | – |
JAZZ | Exit | JAZZ PHARMACEUTICALS PLCcall | $0 | – | -119,000 | -100.0% | -0.94% | – |
DT | Exit | DYNATRACE INC | $0 | – | -255,800 | -100.0% | -1.10% | – |
ABCL | Exit | ABCELLERA BIOLOGICS INC | $0 | – | -971,297 | -100.0% | -1.18% | – |
UHS | Exit | UNIVERSAL HLTH SVCS INCcl b | $0 | – | -141,515 | -100.0% | -1.19% | – |
CRWD | Exit | CROWDSTRIKE HLDGS INCcl a | $0 | – | -80,100 | -100.0% | -1.19% | – |
PAYC | Exit | PAYCOM SOFTWARE INC | $0 | – | -41,210 | -100.0% | -1.24% | – |
SE | Exit | SEA LTDsponsord ads | $0 | – | -66,890 | -100.0% | -1.29% | – |
TWLO | Exit | TWILIO INCcl a | $0 | – | -78,225 | -100.0% | -1.51% | – |
VRTX | Exit | VERTEX PHARMACEUTICALS INCcall | $0 | – | -140,000 | -100.0% | -1.54% | – |
XOM | Exit | EXXON MOBIL CORP | $0 | – | -594,700 | -100.0% | -2.12% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
- Charles I. Clough, Jr. #1
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-02-14
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
BK OF AMERICA CORP | 37 | Q3 2023 | 5.0% |
MICROSOFT CORP | 35 | Q3 2023 | 5.5% |
CITIGROUP INC | 33 | Q2 2021 | 5.8% |
JPMORGAN CHASE & CO | 33 | Q3 2023 | 3.2% |
D R HORTON INC | 32 | Q3 2023 | 3.2% |
TRANSDIGM GROUP INC | 32 | Q3 2023 | 3.9% |
VERTEX PHARMACEUTICALS INC | 32 | Q2 2023 | 1.6% |
JAZZ PHARMACEUTICALS PLC | 32 | Q3 2023 | 1.6% |
VERACYTE INC | 31 | Q2 2023 | 0.8% |
LENNAR CORP | 30 | Q1 2022 | 2.7% |
View CLOUGH CAPITAL PARTNERS L P's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
Checkmate Pharmaceuticals, Inc. | February 14, 2022 | 1,137,764 | 5.3% |
Correvio Pharma Corp.Sold out | February 24, 2020 | 0 | 0.0% |
Cardiome Pharma Corp | April 27, 2018 | 2,058,763 | 5.9% |
CARVANA CO. | April 27, 2018 | 1,072,050 | 3.6% |
HEALTHWAYS, INC | January 12, 2016 | 1,850,289 | 5.1% |
Kura Oncology, Inc. | January 12, 2016 | 1,076,333 | 5.0% |
VERACYTE, INC. | January 12, 2016 | 1,049,054 | 3.8% |
Solar Senior Capital Ltd. | February 11, 2013 | 325,093 | 2.8% |
MAGAL SECURITY SYSTEMS LTDSold out | March 23, 2011 | 0 | 0.0% |
BIOSPHERE MEDICAL INCSold out | February 10, 2011 | 0 | 0.0% |
View CLOUGH CAPITAL PARTNERS L P's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-05-15 |
13F-HR | 2024-02-14 |
13F-HR | 2023-11-14 |
13F-HR | 2023-08-14 |
13F-HR | 2023-05-15 |
13F-HR | 2023-02-14 |
13F-HR | 2022-11-14 |
13F-HR | 2022-08-16 |
13F-HR | 2022-05-16 |
13F-HR | 2022-02-14 |
View CLOUGH CAPITAL PARTNERS L P's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.